OBJECTIVE: HbA1c levels are increasingly measured in screening for diabetes; we investigated whether HbA1c may simultaneously improve cardiovascular disease (CVD) risk assessment, using QRISK3, American College of Cardiology/American Heart Association (ACC/AHA), and Systematic COronary Risk Evaluation (SCORE) scoring systems. RESEARCH DESIGN AND METHODS: UK Biobank participants without baseline CVD or known diabetes (n = 357,833) were included. Associations of HbA1c with CVD was assessed using Cox models adjusting for classical risk factors. Predictive utility was determined by the C-index and net reclassification index (NRI). A separate analysis was conducted in 16,596 participants with known baseline diabetes. RESULTS: Incident fata...
Objectives: Glycated haemoglobin A(1c) (HbA(1c)) measurement is recommended as an alternative to fas...
Patients with diabetes mellitus are at increased risk of developing numerous serious health problems...
Objective: Associations of glycated hemoglobin A1c (HbA1c) levels to incident coronary and cardiovas...
IMPORTANCE The value of measuring levels of glycated hemoglobin (HbA(1c)) for the prediction of firs...
Background: Biomarkers may contribute to improved cardiovascular risk estimation. Glycated hemoglobi...
Importance The value of measuring levels of glycated hemoglobin (HbA1c) for the prediction of first ...
There is a continuous relationship between glycated hemoglobin (HbA(1c)) and coronary heart disease ...
Objective: To examine the relationship between glycated haemoglobin A1c (HbA1c) levels and the risk ...
Background: Biomarkers may contribute to improved cardiovascular risk estimation. Glycated hemoglobi...
Background: Biomarkers may contribute to improved cardiovascular risk estimation. Glycated hemoglobi...
Aims: The long‐term effect of glycated haemoglobin A1c(HbA1c) level on cardiovascular disease(CVD) r...
Hemoglobin A1C (HbA1C) is associated with increased risk of cardiovascular events, but its use for p...
Background: The role of HbA1C in predicting the outcomes of acute coronary syndrome remains controve...
Objectives: Glycated haemoglobin A(1c) (HbA(1c)) measurement is recommended as an alternative to fas...
Patients with diabetes mellitus are at increased risk of developing numerous serious health problems...
Objective: Associations of glycated hemoglobin A1c (HbA1c) levels to incident coronary and cardiovas...
IMPORTANCE The value of measuring levels of glycated hemoglobin (HbA(1c)) for the prediction of firs...
Background: Biomarkers may contribute to improved cardiovascular risk estimation. Glycated hemoglobi...
Importance The value of measuring levels of glycated hemoglobin (HbA1c) for the prediction of first ...
There is a continuous relationship between glycated hemoglobin (HbA(1c)) and coronary heart disease ...
Objective: To examine the relationship between glycated haemoglobin A1c (HbA1c) levels and the risk ...
Background: Biomarkers may contribute to improved cardiovascular risk estimation. Glycated hemoglobi...
Background: Biomarkers may contribute to improved cardiovascular risk estimation. Glycated hemoglobi...
Aims: The long‐term effect of glycated haemoglobin A1c(HbA1c) level on cardiovascular disease(CVD) r...
Hemoglobin A1C (HbA1C) is associated with increased risk of cardiovascular events, but its use for p...
Background: The role of HbA1C in predicting the outcomes of acute coronary syndrome remains controve...
Objectives: Glycated haemoglobin A(1c) (HbA(1c)) measurement is recommended as an alternative to fas...
Patients with diabetes mellitus are at increased risk of developing numerous serious health problems...
Objective: Associations of glycated hemoglobin A1c (HbA1c) levels to incident coronary and cardiovas...